scholarly journals Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015

2016 ◽  
Vol 10 (1-2) ◽  
pp. 46 ◽  
Author(s):  
Wassim Kassouf ◽  
Armen Aprikian ◽  
Peter Black ◽  
Girish Kulkarni ◽  
Jonathan Izawa ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Real Life ◽  
Population Based ◽  
Unify Treatment ◽  
Supporting Evidence ◽  
Urologic Oncology ◽  
Consensus Document ◽  
Medical Oncologists ◽  
Patient Representatives

This initiative was undertaken in response to concerns regarding the variation in management and in outcomes of patients with bladder cancer throughout centres and geographical areas in Canada. Population-based data have also revealed that real-life survival is lower than expected based on data from clinical trials and/or academic centres. To address these perceived shortcomings and attempt to streamline and unify treatment approaches to bladder cancer in Canada, a multidisciplinary panel of expert clinicians was convened last fall for a two-day working group consensus meeting. The panelists included urologic oncologists, medical oncologists, radiation oncologists, patient representatives, a genitourinary pathologist, and an enterostomal therapy nurse. The following recommendations and summaries of supporting evidence represent the results of the presentations, debates, and discussions. Methodology

scholarly journals Merging science education, citizen science and general population noise exposure data collection in the battle against noise pollution

2021 ◽  
Vol 263 (3) ◽  
pp. 2996-3007
Author(s):  
Luc Dekoninck ◽  
Wim Van Beggenhout ◽  
Mieke Sterken
Keyword(s):  
Quality Of Life ◽  
Citizen Science ◽  
Noise Exposure ◽  
Real Life ◽  
Noise Pollution ◽  
Population Based ◽  
Policy Support ◽  
Monitoring Data ◽  
Science Data

Science, Technology, Engineering, Mathematics in education is commonly referred to as STEM. The last decades illustrate that our society is transferring into an ever accelerating technological environment. In parallel, the general public became an important driving force in collecting citizen science data to trigger legislative pressure and impact on policy makers to accelerate the improvement of their quality of life. That practice is currently extending into the environmental impact of noise related quality of life. This publication suggests to merge those educational STEM goals, citizen science monitoring and the need for population based noise monitoring data for efficient policy support. The presented educational project can be regarded as a proof-of-concept and can be repeated in different schools and classes every year. This approach has the potential to acquire abundant noise monitoring data and provides an unbiased population sampling dataset by design. This population driven involvement allows to assess real-life and long-term noise policy impact and could become a fundamental pillar in achieving the overall societal goal of improving noise related environmental quality of life.

The neoadjuvant management of muscle-invasive bladder cancer (MIBC) in Canada: A national survey of urologists.

2012 ◽  
Vol 30 (5_suppl) ◽  
pp. 303-303 ◽  
Author(s):  
Srikala S. Sridhar ◽  
Kim N. Chi ◽  
Scott A. North ◽  
Peter C. Black ◽  
Lori Wood ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Renal Function ◽  
Medical Oncology ◽  
Performance Status ◽  
Standard Of Care ◽  
Full Time ◽  
Urologic Oncology ◽  
Poor Renal Function ◽  
Medical Oncologists ◽  
Muscle Invasive

303 Background: There is level 1 evidence and a 5% absolute survival benefit supporting the use of cisplatin-based neoadjuvant chemotherapy (NC) for the management of MIBC. Despite this, it is well known that the majority of eligible patients undergoing cystectomy do not receive NC. We previously surveyed medical oncologists and found that the majority will offer NC to MIBC patients depending on stage, renal function, performance status (PS), and comorbidities. However, the number of MIBC patients being referred for consideration of NC by urologists remains low. The aim of this followup survey to urologists was to better understand their approach to MIBC, and referral patterns for NC. Methods: A survey consisting of 24 questions was administered to Canadian urologists belonging to the Canadian Urologic Oncology Group. Respondents completed the survey and mailed/faxed back their responses. The survey was similar to, but not identical to the previous medical oncology survey. Results: Of the 25 respondents, 21/25 (84%) were academic, >90% were in full-time practice, and 72% were practising for >10 yrs. Most (84%) treated over 20 bladder cancer cases annually. Overall, 22/25 (80%) will offer a NC approach if appropriate. In 2009, 9/24 (38%) sent >6 referrals for NC; 2/24 (25%) sent 5-6 referrals, 6/24 (20%) sent 3-4 referrals, and 5/24 (8%) sent 1-2 referrals. NC was offered as standard of care or to downsize tumors. Initial staging included cystoscopy, CT chest/abdo/pelvis and bone scan. Key factors cited for not offering NC were: T2a disease, GFR <40ml/min, age >85 or PS 3 or 4. Average time from NC to cystectomy was 4-6 wks. Conclusions: The majority of academic urologists in Canada will refer MIBC patients for NC except those with T2a disease, poor renal function, age >85 or poor PS. Non-academic urologists are underrepresented in this survey, and may represent the group facing the greatest challenges in offering NC, due to issues such as access to medical oncology, or lack of local expertise in managing MIBC. Targeting non-academic urologists, and encouraging consultation with a medical oncologist for all patients with MIBC, may lead to increased utilization of NC, and better outcomes in this disease.

scholarly journals Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists

2014 ◽  
Vol 8 (9-10) ◽  
pp. 309 ◽  
Author(s):  
Tina Hsu ◽  
Peter C Black ◽  
Kim N Chi ◽  
Christina M Canil ◽  
Bernie J Eigl ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Renal Function ◽  
Performance Status ◽  
Standard Of Care ◽  
Invasive Bladder Cancer ◽  
Muscle Invasive Bladder Cancer ◽  
Urologic Oncology ◽  
Canadian Association ◽  
Medical Oncologists ◽  
Muscle Invasive

Introduction: Uptake of neoadjuvant chemotherapy (NC) for muscle-invasive bladder cancer (MIBC) has been low despite evidence of a survival benefit. The primary aim of this study was to better understand why the rates are low and determine what factors specifically influence the decision to recommend NC for MIBC.Methods: A 31-question survey was emailed between 2009 and 2011 to medical oncologists belonging to the Canadian Association of Genitourinary Medical Oncologists (CAGMO); and to urologists belonging to the Canadian Urologic Oncology Group (CUOG). We gathered data on practice characteristics, referrals for NC, factors influencing NC use, and chemotherapy regimens offered. Responses were summarized using descriptive statistics.Results: In total, 26/30 (87%) medical oncologists and 25/84 (30%) urologists, who were primarily academic, completed the survey. Most clinicians (medical oncologists 96%, urologists 88%) recommended NC for MIBC, because they considered it to be the standard of care, but most medical oncologists saw ≤6 referrals annually. Performance status, presence of comorbidities and renal function were key considerations in offering NC. NC was not offered if performance status ≥2 (medical oncologists 38%, urologists 44%), age >80 (medical oncologists 46%, urologists 39%), or glomerular filtration rate ≤40 mL/min (medical oncologists 81%, urologists 50%).Conclusions: Most academic clinicians in Canada believe that cisplatin-based combination NC is the standard of care for MIBC and recommend it for patients with adequate performance status and renal function. Using a multidisciplinary approach to treat this disease may be one strategy to increase referral rates for NC and uptake of NC.

scholarly journals Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions

2014 ◽  
Vol 2014 ◽  
pp. 1-6 ◽  
Author(s):  
N. G. Cowan ◽  
Y. Chen ◽  
T. M. Downs ◽  
B. H. Bochner ◽  
A. B. Apolo ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Univariate Analysis ◽  
Utilization Rate ◽  
Urologic Oncology ◽  
Medical Oncologists ◽  
Level 1 ◽  
Muscle Invasive ◽  
Question Survey ◽  
Descriptive Statistical Analysis

Objectives. Level 1 evidence supports the use of neoadjuvant chemotherapy (NAC) to improve overall survival in muscle invasive bladder cancer; however utilization rates remain low. The aims of our study were to determine factors associated with NAC use, to more clearly define reasons for low utilization, and to determine the current rate of NAC use among urologic oncologists.Materials and Methods. Active members of the Society for Urologic Oncology were provided a 20-question survey. Descriptive statistical analysis was conducted for each question and univariate analysis was performed.Results. We achieved a response rate of 21%. Clinical T3/T4 disease was the most often selected reason for recommending NAC (87%). Concerns with recommending NAC were age and comorbidities (54%) followed by delay in surgery (35%). An association was identified between urologic oncologists who discussed NAC with >90% of their patients and medical oncologists “always” recommending NAC (P=0.0009). NAC utilization rate was between 30 and 57%.Conclusions. Amongst this highly specialized group of respondents, clinical T3-T4 disease was the most common reason for implementation of NAC. Respondents who frequently discussed NAC were more likely to report their medical oncologist always recommending NAC. Reported NAC use was higher in this surveyed group (30–57%) compared with recently published rates.

scholarly journals Health-related quality of life among non-muscle-invasive bladder cancer survivors: a population-based study

2019 ◽  
Vol 125 (1) ◽  
pp. 38-48 ◽  
Author(s):  
Ahrang Jung ◽  
Matthew E. Nielsen ◽  
Jamie L. Crandell ◽  
Mary H. Palmer ◽  
Sophia K. Smith ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Bladder Cancer ◽  
Population Based ◽  
Health Related Quality ◽  
Muscle Invasive Bladder Cancer ◽  
Population Based Study ◽  
Related Quality ◽  
Health Related ◽  
Muscle Invasive

Lymph node counts are valid indicators of the quality of surgical care in bladder cancer: A population-based study

2015 ◽  
Vol 33 (10) ◽  
pp. 425.e15-425.e23 ◽  
Author(s):  
D. Robert Siemens ◽  
William J. Mackillop ◽  
Yingwei Peng ◽  
Xuejiao Wei ◽  
David Berman ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Lymph Node ◽  
Surgical Care ◽  
Population Based ◽  
Population Based Study

Assessing the quality of public health in the Russian Federation and Israel: Main problems and solutions

2020 ◽  
Vol 19 (4) ◽  
pp. 618-632
Author(s):  
A.S. Panchenko
Keyword(s):  
Public Health ◽  
Russian Federation ◽  
Population Based ◽  
The Public ◽  
Disability Adjusted Life ◽  
Problems And Solutions ◽  
The Russian Federation ◽  
Disability Adjusted Life Year ◽  
Practical Recommendations

Subject. The article addresses the public health in the Russian Federation and Israel. Objectives. The focus is on researching the state of public health in Russia and Israel, using the Global Burden of Disease (GBD) project methodology, identifying problem areas and searching for possible ways to improve the quality of health of the Russian population based on the experience of Israel. Methods. The study draws on the ideology of the GBD project, which is based on the Disability-Adjusted Life-Year (DALY) metric. Results. The paper reveals the main causes of DALY losses and important risk factors for cancer for Russia and Israel. The findings show that the total DALY losses for Russia exceed Israeli values. The same is true for cancer diseases. Conclusions. Activities in Israel aimed at improving the quality of public health, the effectiveness of which has been proven, can serve as practical recommendations for Russia. The method of analysis, using the ideology of the GBD project, can be used as a tool for quantitative and comparative assessment of the public health.

Sign in / Sign up

Export Citation Format

Share Document